| Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 12043* | 2021 |
| Hypoxia—a key regulatory factor in tumour growth AL Harris Nature reviews cancer 2 (1), 38-47, 2002 | 6018 | 2002 |
| Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials Early Breast Cancer Trialists' Collaborative Group The Lancet 366 (9503), 2087-2106, 2005 | 5881 | 2005 |
| Breast cancer classification and prognosis based on gene expression profiles from a population-based study C Sotiriou, SY Neo, LM McShane, EL Korn, PM Long, A Jazaeri, P Martiat, ... Proceedings of the National Academy of Sciences 100 (18), 10393-10398, 2003 | 2654 | 2003 |
| Detection of elevated levels of tumour‐associated microRNAs in serum of patients with diffuse large B‐cell lymphoma CH Lawrie, S Gal, HM Dunlop, B Pushkaran, AP Liggins, K Pulford, ... British journal of haematology 141 (5), 672-675, 2008 | 2313 | 2008 |
| Polychemotherapy for early breast cancer: an overview of the randomised trials Early Breast Cancer Trialists' Collaborative Group The Lancet 352 (9132), 930-942, 1998 | 2130 | 1998 |
| The expression and distribution of the hypoxia-inducible factors HIF-1α and HIF-2α in normal human tissues, cancers, and tumor-associated macrophages KL Talks, H Turley, KC Gatter, PH Maxwell, CW Pugh, PJ Ratcliffe, ... The American journal of pathology 157 (2), 411-421, 2000 | 1706 | 2000 |
| Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma RD Leek, CE Lewis, R Whitehouse, M Greenall, J Clarke, AL Harris Cancer research 56 (20), 4625-4629, 1996 | 1550 | 1996 |
| Hypoxia-inducible expression of tumor-associated carbonic anhydrases CC Wykoff, NJP Beasley, PH Watson, KJ Turner, J Pastorek, A Sibtain, ... Cancer research 60 (24), 7075-7083, 2000 | 1521 | 2000 |
| Increased expression of mutant forms of p53 oncogene in primary lung cancer R Iggo, J Bartek, D Lane, K Gatter, AL Harris The Lancet 335 (8691), 675-679, 1990 | 1349 | 1990 |
| Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse GJFSB Bates, CLRD Han, JFHAL Garcia, AH Banham Journal of clinical oncology 24 (34), 5373-5380, 2006 | 1348 | 2006 |
| Sizing and phenotyping of cellular vesicles using Nanoparticle Tracking Analysis RA Dragovic, C Gardiner, AS Brooks, DS Tannetta, DJP Ferguson, P Hole, ... Nanomedicine: Nanotechnology, Biology and Medicine 7 (6), 780-788, 2011 | 1317 | 2011 |
| Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor RJ Appelhoff, YM Tian, RR Raval, H Turley, AL Harris, CW Pugh, ... Journal of Biological Chemistry 279 (37), 38458-38465, 2004 | 1240 | 2004 |
| Effects of radiotherapy and surgery in early breast cancer—an overview of the randomized trials Early Breast Cancer Trialists' Collaborative Group New England Journal of Medicine 333 (22), 1444-1456, 1995 | 1200 | 1995 |
| Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor β-1, platelet-derived endothelial … M Relf, S LeJeune, PAE Scott, S Fox, K Smith, R Leek, A Moghaddam, ... Cancer research 57 (5), 963-969, 1997 | 1172 | 1997 |
| Epidermal-growth-factor receptor status as predictor of early recurrence of and death from breast cancer J Richard, C Sainsbury, GK Needham, JR Farndon, AJ Malcolm, ... The Lancet 329 (8547), 1398-1402, 1987 | 1134 | 1987 |
| Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma RR Raval, KW Lau, MGB Tran, HM Sowter, SJ Mandriota, JL Li, CW Pugh, ... Molecular and cellular biology 25 (13), 5675-5686, 2005 | 1132 | 2005 |
| SYSTEMIC TREATMENT OF EARLY BREAST-CANCER BY HORMONAL, CYTOTOXIC, OR IMMUNE THERAPY-133 RANDOMIZED TRIALS INVOLVING 31000 RECURRENCES AND 24000 DEATHS AMONG 75000 WOMEN. 2. O Abe, R Abe, K Asaishi, K Enomoto, T Hattori, Y Ino, K Kikuchi, ... Lancet 339 (8785), 71-85, 1992 | 1081 | 1992 |
| Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series C Desmedt, F Piette, S Loi, Y Wang, F Lallemand, B Haibe-Kains, G Viale, ... Clinical cancer research 13 (11), 3207-3214, 2007 | 1067 | 2007 |
| How cancer metabolism is tuned for proliferation and vulnerable to disruption A Schulze, AL Harris Nature 491 (7424), 364-373, 2012 | 954 | 2012 |
Stephen FoxMelbourneVerified email at petermac.org
